Beurs gesloten -
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
1,48 USD | -1,99% | +4,96% | -15,91% |
Omzet 2024 * | - | Omzet 2025 * | - | Marktkapitalisatie | 72,58 mln. 67,62 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2024 * | -33 mln. -30,74 mln. | Nettowinst (verlies) 2025 * | -45 mln. -41,92 mln. | EV/omzet 2024 * | - |
Nettoliquiditeiten 2024 * | - 0 | Nettoliquiditeiten 2025 * | - 0 | EV/omzet 2025 * | - |
K/w-verhouding 2024 * |
-2,6
x | K/w-verhouding 2025 * |
-2,35
x | Werknemers | 28 |
Dividendrendement 2024 * |
-
| Dividendrendement 2025 * |
-
| Vrij verhandelbaar | 89,43% |
Recentste transcriptie over Corvus Pharmaceuticals, Inc.
1 dag | -1,99% | ||
1 week | +4,96% | ||
Lopende maand | -16,85% | ||
1 maand | -15,91% | ||
3 maanden | -27,80% | ||
6 maanden | +28,70% | ||
Lopend jaar | -15,91% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Richard Miller
CEO | Chief Executive Officer | 73 | 27-01-14 |
Leiv Lea
DFI | Director of Finance/CFO | 70 | 27-01-14 |
James Rosenbaum
CTO | Chief Tech/Sci/R&D Officer | - | 21-07-22 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Richard Miller
CEO | Chief Executive Officer | 73 | 27-01-14 |
Ian Clark
BRD | Director/Board Member | 62 | 03-01-17 |
Terry Gould
BRD | Director/Board Member | 67 | 01-11-14 |
Datum | Koers | Variatie | Volume |
---|---|---|---|
25-04-24 | 1,48 | -1,99% | 66 282 |
24-04-24 | 1,51 | -1,31% | 90 571 |
23-04-24 | 1,53 | +6,25% | 137 350 |
22-04-24 | 1,44 | +2,86% | 130 642 |
19-04-24 | 1,4 | -0,71% | 58 804 |
uitgestelde koers Nasdaq, 25 april 2024 om 22:00 uur
Meer koersenHerzieningen van WPA
Vaira. 1 jan. | Kapi. | |
---|---|---|
-15,91% | 72,58 mln. | |
+1,12% | 42,59 mld. | |
+6,77% | 40,65 mld. | |
+47,02% | 40,57 mld. | |
-11,96% | 26,77 mld. | |
+6,01% | 24,81 mld. | |
-24,92% | 18,17 mld. | |
-3,63% | 11,7 mld. | |
+27,16% | 12,05 mld. | |
+7,30% | 11,1 mld. |